Win Surachetpong

Prof. Dr. Win Surachetpong

Aquaculture, University of Stirling, Stirling, UK
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Reviews in Aquaculture
Verified
Journal Article
Open access
MRMelba Bondad Reantaso
Melba Bondad Reantaso
BMBrett MacKinnon
Brett MacKinnon
IKIddya Karunasagar
Iddya Karunasagar
SFSophie Fridman
Sophie Fridman
VAVictoria Alday‐Sanz
Victoria Alday‐Sanz
ACAndrea Caputo
Andrea Caputo
With the rapid growth of the aquaculture production since the 1980s, there has been a concomitant increase in disease outbreaks. The injudicious and/or incorrect use of antimicrobial agents against diseases of farmed aquatic species poses a considerable threat to the development and growth of a successful and sustainable aquaculture industry. An increase in antimicrobial resistance (AMR) is an important consequence, resulting to the difficulty in treating common bacterial diseases in populations of aquatic organisms, combined with the presence of antibiotic residues in food fish and their products, leading to import refusals and negative impacts on international trade. To reduce the frequency of AMR, good aquaculture and effective biosecurity practices should include the prudent and responsible use of antibiotics and also consider the use of alternatives to antibiotics, in addition to disease prevention management. This article reviews the literature discussing the scope of the problem pertaining to antibiotic use, the emergence of AMR in aquaculture and to consider and discuss viable alternatives (e.g., vaccination, bacteriophages, quorum quenching, probiotics and prebiotics, chicken egg yolk antibody and medicinal plant derivative). We also discuss lessons learnt, from specific case studies such as the vaccination of farmed salmon in Norway and the use of ‘specific pathogen‐free’ seed—as primary and essential part of a biosecurity strategy.

1 June 2017 in Emerging Infectious Diseases
Verified
Journal Article
Open access
Win SurachetpongWin Surachetpong
Win Surachetpong
TJTaveesak Janetanakit
Taveesak Janetanakit
NNNutthawan Nonthabenjawan
Nutthawan Nonthabenjawan
PTPuntanat Tattiyapong
Puntanat Tattiyapong
kwanrawee sirikanchanakwanrawee sirikanchana
kwanrawee sirikanchana
AAAlongkorn Amonsin
Alongkorn Amonsin
During 2015–2016, several outbreaks of tilapia lake virus infection occurred among tilapia in Thailand. Phylogenetic analysis showed that the virus from Thailand grouped with a tilapia virus (family Orthomyxoviridae) from Israel. This emerging virus is a threat to tilapia aquaculture in Asia and worldwide.

23 August 2020 in Journal of Fish Diseases
Verified
Journal Article
Closed access
PDF file
Win SurachetpongWin Surachetpong
Win Surachetpong
SRSri Rajiv Kumar Roy
Sri Rajiv Kumar Roy
PNPamela Nicholson
Pamela Nicholson

1 August 2017 in Veterinary Microbiology
Verified
Journal Article
Closed access
PTPuntanat Tattiyapong
Puntanat Tattiyapong
WDWorawan Dachavichitlead
Worawan Dachavichitlead
Win SurachetpongWin Surachetpong
Win Surachetpong


5 December 2022 in Reviews in Aquaculture
Verified
Journal Article
Open access
BWBei Wang
Bei Wang
Kim ThompsonKim Thompson
Kim Thompson
EWEakapol Wangkahart
Eakapol Wangkahart
JYJidapa Yamkasem
Jidapa Yamkasem
MRMelba Bondad Reantaso
Melba Bondad Reantaso
Win SurachetpongWin Surachetpong
Win Surachetpong
Various emerging and re‐emerging diseases, such as streptococcosis, tilapia lake virus disease and infectious spleen and kidney necrosis virus disease, have had a significant economic impact on the tilapia industry over the last decade. These diseases have resulted in high levels of morbidity and mortality, production losses and trade restrictions. In the absence of effective husbandry management, disease prevention strategies and appropriate biosecurity measures, infectious diseases will continue to challenge the sustainability of global tilapia aquaculture. Strategies used to reduce the impact of disease include feeding probiotic and prebiotic supplements to enhance tilapia health and to modulate the fish's gut microbiota to improve gut health. Herbal medicines and immunostimulants are also used to enhance immunity to disease, while vaccines are available, or are under development, for a number of economically important pathogens affecting tilapia culture. This review provides an overview of the benefits of enhancing the immune response of tilapia to improve their health, and in turn reduce the levels of pathogens within tilapia farming systems.